taurine has been researched along with Cirrhosis in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine treatment markedly reduced laminectomy-induced epidural fibrosis in rat models." | 7.83 | Taurine Reduced Epidural Fibrosis in Rat Models after Laminectomy via Downregulating EGR1. ( Cao, X; Chen, H; Ge, D; Ge, Y; Que, J; Sui, T; Tang, J; Yang, L, 2016) |
| " We reported that taurine had an anti-fibrotic effect in a dibutyltin dichloride (DBTC)-chronic pancreatitis model." | 7.78 | Effect of taurine on acinar cell apoptosis and pancreatic fibrosis in dibutyltin dichloride-induced chronic pancreatitis. ( Koide, N; Matsushita, K; Mizushima, T; Ochi, K; Sawa, K; Shirahige, A; Tanimoto, M; Tanioka, H, 2012) |
| "Pancreatic fibrosis induced by DBTC was improved remarkably by the oral administration of the taurine-containing diet." | 7.74 | Oral administration of taurine improves experimental pancreatic fibrosis. ( Ichimura, M; Koide, N; Matsushita, K; Mizushima, T; Ochi, K; Sawa, K; Shinji, T; Shirahige, A; Tanimoto, M; Tanioka, H, 2008) |
| " The aim of this study was to investigate the effects of taurine on oxidative capacity and fibrosis in experimental chronic rat pancreatic fibrosis." | 7.73 | Antioxidant treatment with taurine ameliorates chronic pancreatitis in an experimental rat model. ( Akay, C; Comert, B; Deveci, S; Inal, V; Isik, AT; Mas, MR; Mas, N; Tasci, I; Yamanel, L, 2006) |
| "This study was undertaken to investigate the effect of taurine on the infiltration of macrophages and the progression of renal interstitial fibrosis in the kidneys of rats treated with cisplatin (CDDP)." | 7.71 | Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. ( Hosokawa, T; Kurasaki, M; Saito, S; Saito, T; Sato, S; Yamate, J, 2002) |
| "Taurine (TAU) is an abundant amino acid with substantial anti-inflammatory and antioxidative properties." | 5.72 | Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation. ( Abdoli, N; Azarpira, N; Heidari, R; Lu, Y; Ma, Y; Manthari, RK; Mazloomi, S; Mehrabani, PS; Mingyu, Y; Mobasheri, A; Mousavifaraz, A; Nadgaran, A; Niknahad, H; Nikoozadeh, A; Ommati, MM; Rezaei, M; Sadeghian, I; Tang, Z; Xin, H; Xu, D, 2022) |
| "Taurine has been shown to protect against lung injury induced by various oxidants including ozone, nitrogen dioxide, amiodarone, and paraquat and to protect against bleomycin-induced lung injury in combination with niacin." | 5.35 | Protection of bleomycin-induced fibrosis and inflammation by taurine. ( Gordon, RE; Park, E; Park, SY; Schuller-Levis, G; Wang, C, 2009) |
| "Betaine or taurine was also found to decrease serum transaminase activities and hepatic lipid peroxidation without any change in hepatic antioxidant system in rats with hepatic fibrosis." | 5.32 | Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication. ( Balkan, J; Cevikbaş, U; Erman, F; Koçak-Toker, N; Uysal, M, 2004) |
| " Molecular studies have shown that long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) participate in renal fibrosis, while the roles of lncRNA taurine upregulated gene 1 (TUG1) and miR-140-3p in hyperuricemia-induced renal fibrosis remain less investigated." | 4.12 | lncRNA TUG1 regulates hyperuricemia-induced renal fibrosis in a rat model. ( Hu, L; Ma, C; Wei, J; Zhang, H; Zhang, Y, 2022) |
| " The present study assessed the ability of taurine (TAU) to alleviate or prevent AMK-induced nephrotoxicity if co-administrated with AMK focusing on inflammation, apoptosis, and fibrosis." | 4.02 | The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation. ( Azmy, A; El-Amir, A; Madbouly, N; Salama, A, 2021) |
| "Taurine treatment markedly reduced laminectomy-induced epidural fibrosis in rat models." | 3.83 | Taurine Reduced Epidural Fibrosis in Rat Models after Laminectomy via Downregulating EGR1. ( Cao, X; Chen, H; Ge, D; Ge, Y; Que, J; Sui, T; Tang, J; Yang, L, 2016) |
| " We reported that taurine had an anti-fibrotic effect in a dibutyltin dichloride (DBTC)-chronic pancreatitis model." | 3.78 | Effect of taurine on acinar cell apoptosis and pancreatic fibrosis in dibutyltin dichloride-induced chronic pancreatitis. ( Koide, N; Matsushita, K; Mizushima, T; Ochi, K; Sawa, K; Shirahige, A; Tanimoto, M; Tanioka, H, 2012) |
| "To study the differential expression of proteins between natural taurine treated hepatic stellate cells and controls, and investigate the underlying regulatory mechanism of natural taurine in inhibiting hepatic fibrosis." | 3.76 | Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis. ( Deng, X; Liang, J; Lin, ZX; Wu, FS; Zhang, YP; Zhang, ZW, 2010) |
| "Pancreatic fibrosis induced by DBTC was improved remarkably by the oral administration of the taurine-containing diet." | 3.74 | Oral administration of taurine improves experimental pancreatic fibrosis. ( Ichimura, M; Koide, N; Matsushita, K; Mizushima, T; Ochi, K; Sawa, K; Shinji, T; Shirahige, A; Tanimoto, M; Tanioka, H, 2008) |
| " The aim of this study was to investigate the effects of taurine on oxidative capacity and fibrosis in experimental chronic rat pancreatic fibrosis." | 3.73 | Antioxidant treatment with taurine ameliorates chronic pancreatitis in an experimental rat model. ( Akay, C; Comert, B; Deveci, S; Inal, V; Isik, AT; Mas, MR; Mas, N; Tasci, I; Yamanel, L, 2006) |
| "This study was undertaken to investigate the effect of taurine on the infiltration of macrophages and the progression of renal interstitial fibrosis in the kidneys of rats treated with cisplatin (CDDP)." | 3.71 | Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. ( Hosokawa, T; Kurasaki, M; Saito, S; Saito, T; Sato, S; Yamate, J, 2002) |
| "Taurine (TAU) is an abundant amino acid with substantial anti-inflammatory and antioxidative properties." | 1.72 | Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation. ( Abdoli, N; Azarpira, N; Heidari, R; Lu, Y; Ma, Y; Manthari, RK; Mazloomi, S; Mehrabani, PS; Mingyu, Y; Mobasheri, A; Mousavifaraz, A; Nadgaran, A; Niknahad, H; Nikoozadeh, A; Ommati, MM; Rezaei, M; Sadeghian, I; Tang, Z; Xin, H; Xu, D, 2022) |
| "Patients with biliary atresia (i." | 1.38 | Intestinal synthesis and secretion of bile salts as an adaptation to developmental biliary atresia in the sea lamprey. ( Chung-Davidson, YW; Li, K; Li, W; Wang, H; Yeh, CY, 2012) |
| "Taurine has been shown to protect against lung injury induced by various oxidants including ozone, nitrogen dioxide, amiodarone, and paraquat and to protect against bleomycin-induced lung injury in combination with niacin." | 1.35 | Protection of bleomycin-induced fibrosis and inflammation by taurine. ( Gordon, RE; Park, E; Park, SY; Schuller-Levis, G; Wang, C, 2009) |
| "Betaine or taurine was also found to decrease serum transaminase activities and hepatic lipid peroxidation without any change in hepatic antioxidant system in rats with hepatic fibrosis." | 1.32 | Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication. ( Balkan, J; Cevikbaş, U; Erman, F; Koçak-Toker, N; Uysal, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Ommati, MM | 1 |
| Mobasheri, A | 1 |
| Ma, Y | 1 |
| Xu, D | 1 |
| Tang, Z | 1 |
| Manthari, RK | 1 |
| Abdoli, N | 1 |
| Azarpira, N | 1 |
| Lu, Y | 1 |
| Sadeghian, I | 1 |
| Mousavifaraz, A | 1 |
| Nadgaran, A | 1 |
| Nikoozadeh, A | 1 |
| Mazloomi, S | 1 |
| Mehrabani, PS | 1 |
| Rezaei, M | 1 |
| Xin, H | 1 |
| Mingyu, Y | 1 |
| Niknahad, H | 1 |
| Heidari, R | 1 |
| Zhang, Y | 2 |
| Zhang, H | 1 |
| Hu, L | 1 |
| Wei, J | 1 |
| Ma, C | 1 |
| Madbouly, N | 1 |
| Azmy, A | 1 |
| Salama, A | 1 |
| El-Amir, A | 1 |
| Ito, T | 1 |
| Hanahata, Y | 1 |
| Kine, K | 1 |
| Murakami, S | 1 |
| Schaffer, SW | 1 |
| Chen, DQ | 1 |
| Cao, G | 1 |
| Chen, H | 2 |
| Argyopoulos, CP | 1 |
| Yu, H | 1 |
| Su, W | 1 |
| Chen, L | 1 |
| Samuels, DC | 1 |
| Zhuang, S | 1 |
| Bayliss, GP | 1 |
| Zhao, S | 1 |
| Yu, XY | 1 |
| Vaziri, ND | 1 |
| Wang, M | 1 |
| Liu, D | 1 |
| Mao, JR | 1 |
| Ma, SX | 1 |
| Zhao, J | 1 |
| Shang, YQ | 1 |
| Kang, H | 1 |
| Ye, F | 1 |
| Cheng, XH | 1 |
| Li, XR | 1 |
| Zhang, L | 1 |
| Meng, MX | 1 |
| Guo, Y | 1 |
| Zhao, YY | 1 |
| Yang, L | 1 |
| Tang, J | 1 |
| Ge, D | 1 |
| Sui, T | 1 |
| Que, J | 1 |
| Cao, X | 1 |
| Ge, Y | 1 |
| Schuller-Levis, G | 1 |
| Gordon, RE | 1 |
| Wang, C | 1 |
| Park, SY | 1 |
| Park, E | 1 |
| Deng, X | 1 |
| Liang, J | 1 |
| Lin, ZX | 1 |
| Wu, FS | 1 |
| Zhang, YP | 1 |
| Zhang, ZW | 1 |
| Lee, E | 1 |
| Ryu, GR | 1 |
| Ko, SH | 1 |
| Ahn, YB | 1 |
| Yoon, KH | 1 |
| Ha, H | 1 |
| Song, KH | 1 |
| Kirov, A | 1 |
| Duarte, M | 1 |
| Guay, J | 1 |
| Karolak, M | 1 |
| Yan, C | 1 |
| Oxburgh, L | 1 |
| Prudovsky, I | 1 |
| Yeh, CY | 1 |
| Chung-Davidson, YW | 1 |
| Wang, H | 1 |
| Li, K | 1 |
| Li, W | 1 |
| Matsushita, K | 2 |
| Mizushima, T | 2 |
| Shirahige, A | 2 |
| Tanioka, H | 2 |
| Sawa, K | 2 |
| Ochi, K | 2 |
| Tanimoto, M | 2 |
| Koide, N | 2 |
| Erman, F | 1 |
| Balkan, J | 1 |
| Cevikbaş, U | 1 |
| Koçak-Toker, N | 1 |
| Uysal, M | 1 |
| Mas, MR | 1 |
| Isik, AT | 1 |
| Yamanel, L | 1 |
| Inal, V | 1 |
| Tasci, I | 1 |
| Deveci, S | 1 |
| Mas, N | 1 |
| Comert, B | 1 |
| Akay, C | 1 |
| Ichimura, M | 1 |
| Shinji, T | 1 |
| Cruz, CI | 1 |
| Ruiz-Torres, P | 1 |
| del Moral, RG | 1 |
| Rodríguez-Puyol, M | 1 |
| Rodríguez-Puyol, D | 1 |
| Sato, S | 1 |
| Yamate, J | 1 |
| Saito, T | 1 |
| Hosokawa, T | 1 |
| Saito, S | 1 |
| Kurasaki, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease[NCT05719714] | Phase 1/Phase 2 | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 other studies available for taurine and Cirrhosis
| Article | Year |
|---|---|
Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation.
Topics: Animals; Antioxidants; Bile Ducts; Cholestasis; Fibrosis; Inflammation; Ligation; Liver; Liver Cirrh | 2022 |
lncRNA TUG1 regulates hyperuricemia-induced renal fibrosis in a rat model.
Topics: Animals; Cell Proliferation; Fibrosis; Hyperuricemia; Kidney Diseases; MicroRNAs; Rats; RNA, Long No | 2022 |
The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Apoptosis; Blood Urea Nitrogen; Creatinine; Dose-Response | 2021 |
Tissue Taurine Depletion Induces Profibrotic Pattern of Gene Expression and Causes Aging-Related Cardiac Fibrosis in Heart in Mice.
Topics: Actins; Aging; Animals; Connective Tissue Growth Factor; Fibrosis; Galectin 3; Gene Expression; Hear | 2018 |
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disea | 2019 |
Taurine Reduced Epidural Fibrosis in Rat Models after Laminectomy via Downregulating EGR1.
Topics: Animals; Cells, Cultured; Down-Regulation; Early Growth Response Protein 1; Epidural Space; Fibrobla | 2016 |
Protection of bleomycin-induced fibrosis and inflammation by taurine.
Topics: Animals; Bleomycin; Cell Movement; Chemotaxis; Chromatography, High Pressure Liquid; Cytoprotection; | 2009 |
Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis.
Topics: Apoptosis; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Fibrosis; Flow Cytometry; Gene | 2010 |
Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Cyclic N-Oxides; Cytoprotection; Diabetes Mellitus, | 2011 |
Transgenic expression of nonclassically secreted FGF suppresses kidney repair.
Topics: Animals; Base Sequence; Cell Enlargement; DNA Primers; Endothelial Cells; Fibroblast Growth Factor 1 | 2012 |
Intestinal synthesis and secretion of bile salts as an adaptation to developmental biliary atresia in the sea lamprey.
Topics: Animals; Bile Acids and Salts; Biliary Atresia; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Chroma | 2012 |
Effect of taurine on acinar cell apoptosis and pancreatic fibrosis in dibutyltin dichloride-induced chronic pancreatitis.
Topics: Acinar Cells; Animals; Apoptosis; Blotting, Western; Cell Culture Techniques; Fibrosis; Male; Organo | 2012 |
Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; beta-Alanine; Betaine; Carbon Tetrachlor | 2004 |
Antioxidant treatment with taurine ameliorates chronic pancreatitis in an experimental rat model.
Topics: Animals; Antioxidants; Body Weight; Disease Models, Animal; Fibrosis; Glutathione Peroxidase; Male; | 2006 |
Oral administration of taurine improves experimental pancreatic fibrosis.
Topics: Administration, Oral; Animals; Collagen Type I; Diet; Enzyme Inhibitors; Fibrosis; Interleukin-2; In | 2008 |
Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Extracellul | 2000 |
Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cisplatin; Fibrosis; Immunohistochemistry; Kidney; Macro | 2002 |